194 related articles for article (PubMed ID: 12435521)
1. New immunosuppressive drugs in dermatology (mycophenolate mofetil, tacrolimus): unapproved uses, dosages, or indications.
Assmann T; Ruzicka T
Clin Dermatol; 2002; 20(5):505-14. PubMed ID: 12435521
[No Abstract] [Full Text] [Related]
2. [Mycophenolate mofetil: a new immunosuppressive drug in dermatology and its possible uses].
Geilen CC; Orfanos-Boeckel H; Offermann G; Orfanos CE
Hautarzt; 2000 Feb; 51(2):63-9. PubMed ID: 10743574
[TBL] [Abstract][Full Text] [Related]
3. Psychotropic and neurotropic agents in dermatology: unapproved uses, dosages, or indications.
Koo JY; Ng TC
Clin Dermatol; 2002; 20(5):582-94. PubMed ID: 12435529
[No Abstract] [Full Text] [Related]
4. Topical vitamin D3 analogues: unapproved uses, dosages, or indications.
Parish JL
Clin Dermatol; 2002; 20(5):558-62. PubMed ID: 12435526
[No Abstract] [Full Text] [Related]
5. Miscellaneous treatments, II: niacin and heparin: unapproved uses, dosages, or indications.
Wolf R; Orion E; Matz H; Tüzün Y; Tüzün B
Clin Dermatol; 2002; 20(5):547-57. PubMed ID: 12435525
[No Abstract] [Full Text] [Related]
6. Mycophenolate mofetil: a dermatologic perspective.
Mydlarski PR
Skin Therapy Lett; 2005 Apr; 10(3):1-6. PubMed ID: 15986076
[TBL] [Abstract][Full Text] [Related]
7. Transplant immunosuppressant agents and their role in autoimmune rheumatic diseases.
Mayer DF; Kushwaha SS
Curr Opin Rheumatol; 2003 May; 15(3):219-25. PubMed ID: 12707574
[TBL] [Abstract][Full Text] [Related]
8. [Topical tacrolimus in dermatology: what can one expect?].
Lacour JP
Ann Dermatol Venereol; 2001 Dec; 128(12):1291-4. PubMed ID: 11908129
[No Abstract] [Full Text] [Related]
9. Topical immunotherapy: unapproved uses, dosages, or indications.
Higgins E; du Vivier A
Clin Dermatol; 2002; 20(5):515-21. PubMed ID: 12435522
[No Abstract] [Full Text] [Related]
10. Mycophenolate mofetil and tacrolimus for induction and maintenance therapy after pancreas transplantation.
Gruessner RW; Sutherland DE; Drangstveit MB; West M; Gruessner AC
Transplant Proc; 1998 Mar; 30(2):518-20. PubMed ID: 9532156
[No Abstract] [Full Text] [Related]
11. Photodynamic therapy: unapproved uses, dosages, or indications.
Salva KA
Clin Dermatol; 2002; 20(5):571-81. PubMed ID: 12435528
[No Abstract] [Full Text] [Related]
12. Commentary: unapproved uses, dosages, or indications in dermatology: a physician's reference.
Wolf R
Clin Dermatol; 2002; 20(5):465-6. PubMed ID: 12435515
[No Abstract] [Full Text] [Related]
13. Tacrolimus/"low-dose" mycophenolate mofetil versus microemulsion cyclosporine/"low-dose" mycophenolate mofetil after kidney transplantation--1-year follow-up of a prospective, randomized clinical trial.
Yang HC; Holman MJ; Langhoff E; Ulsh PJ; Dellock CA; Gupta M; Ahsan N
Transplant Proc; 1999; 31(1-2):1121-4. PubMed ID: 10083501
[No Abstract] [Full Text] [Related]
14. [Off-label indications for topical tacrolimus].
Hengge UR
Hautarzt; 2013 Oct; 64(10):752-6. PubMed ID: 24150824
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of mycophenolate mofetil or tacrolimus in children with steroid sensitive but frequently relapsing or steroid-dependent nephrotic syndrome.
Wang J; Mao J; Chen J; Fu H; Shen H; Zhu X; Liu A; Shu Q; Du L
Nephrology (Carlton); 2016 Jan; 21(1):21-7. PubMed ID: 26697959
[TBL] [Abstract][Full Text] [Related]
16. Kidney transplantation in hereditary coproporphyria using tacrolimus and mycophenolate mofetil: a case report.
Telkes G; Pusztai A; Földes K; Langer RM
Transplant Proc; 2013; 45(10):3703-4. PubMed ID: 24315002
[TBL] [Abstract][Full Text] [Related]
17. Dose optimization of mycophenolate mofetil when administered with a low dose of tacrolimus in cadaveric renal transplant recipients.
Squifflet JP; Bäckman L; Claesson K; Dietl KH; Ekberg H; Forsythe JL; Kunzendorf U; Heemann U; Land W; Morales JM; Mühlbacher F; Talbot D; Taube D; Tyden G; van Hooff J; Schleibner S; Vanrenterghem Y;
Transplantation; 2001 Jul; 72(1):63-9. PubMed ID: 11468536
[TBL] [Abstract][Full Text] [Related]
18. Quadruple immunosuppression with basiliximab, tacrolimus, mycophenolate mofetil and prednisone is safe and effective for renal transplantation.
Miura M; Harada H; Fukuzawa N; Iwami D; Taniguchi A; Seki T; Togashi M; Ogawa Y; Satoh H; Hirano T
Clin Transplant; 2005; 19 Suppl 14():54-8. PubMed ID: 15955170
[TBL] [Abstract][Full Text] [Related]
19. A Prospective Randomized, Comparative Trial of High-Dose Mizoribine Versus Mycophenolate Mofetil in Combination With Tacrolimus and Basiliximab for Living Donor Renal Transplant: A Multicenter Trial.
Ishida H; Takahara S; Amada N; Tomikawa S; Chikaraishi T; Takahashi K; Uchida K; Akiyama T; Tanabe K; Toma H;
Exp Clin Transplant; 2016 Oct; 14(5):518-525. PubMed ID: 27733107
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus dosing in mycophenolate-treated patients--can we get away with less?
de Fijter JW
Transplantation; 2011 Jul; 92(1):10-1. PubMed ID: 21654351
[No Abstract] [Full Text] [Related]
[Next] [New Search]
